𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Modulation of indomethacin-induced gastric injury by spermine and taurine in rats

✍ Scribed by Tarek K. Motawi; Hanan M. Abd Elgawad; Nancy N. Shahin


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
174 KB
Volume
21
Category
Article
ISSN
1095-6670

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

This study investigated the involvement of neutrophil infiltration, nitric oxide (NO) generation, and oxidative stress in indomethacin‐induced ulcer and the possible gastroprotective potentials of spermine and taurine, known for their tissue regenerating and antioxidant effects, respectively. Male Wistar albino rats (180–220 g) were allocated into a normal control group, ulcer control group (received a single dose of indomethacin 40 mg–kg p.o.), and two ulcer groups pretreated with spermine (150 mg–kg p.o. 1 h before ulcer induction) and taurine (250 mg–kg i.p. for three consecutive days before ulcer induction). The animals were killed 6 h after indomethacin administration, and the gastric juice, serum, and mucosal tissue were used for gastric injury evaluation. Both modulators significantly ameliorated the indomethacin–induced gastric lesions in glandular mucosa. Notably, spermine exhibited the most pronounced effect as manifested by great reduction in the gastric ulcer index, normalization of the elevated gastric acidity, and triggering of mucin production. Spermine and taurine were able to decrease the elevated levels of gastric myeloperoxidase, conjugated diene, and serum NO. However, the lowered tissue NO content was markedly elevated only by taurine. The antioxidant action of taurine was illustrated by restoration of the depressed content of glutathione, normalization of the inhibited activities of glutathione reductase, and superoxide dismutase. These results suggest that spermine and taurine confer significant gastroprotection against indomethacin‐induced gastric injury with the priority of spermine. Β© 2007 Wiley Periodicals, Inc. J Biochem Mol Toxicol 21:280–288, 2007; Published online in Wiley InterScience (www.interscience.wiley.com). DOI 10.1002/jbt.20194


πŸ“œ SIMILAR VOLUMES


Decreased incidence of indomethacin-indu
✍ Foroogh S. Abtahi; Bijan Djahanguiri πŸ“‚ Article πŸ“… 1975 πŸ› John Wiley and Sons 🌐 English βš– 197 KB πŸ‘ 2 views

## Abstract Gastric mucosal ulceration was produced in rats following intraperitoneal injection of indomethacin (40 mg/kg). The incidence of ulcerations was progressively reduced as the bile flow was diverted progressively distal to the ampulla of Vater. It is suggested that bile reflux into the st

Protective Effect of 4–(3,7,11,15-Tetram
✍ Kenji Fujiwara; Yasuhiko Ohta; Itsuro Ogata; Yuzuru Sato; Yuji Oka; Shigeki Haya πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 333 KB

The effect of 4- (3,7,11,15-tetramethy1-6,10,14hexadecatrienoyl)morpholine (E-07 12), a new synthetic compound, on liver injury induced by two hepatotoxins in rats was studied. Oral doses of E-0712 four times at 0, 6, 12 and 18 hr significantly attenuated elevated SGPT values and prolonged prothromb

Enhancement by vaso-active intestinal pe
✍ Hiroyasu Iishi; Masaharu Tatsuta; Miyako Baba; Shigeru Okuda; Haruo Taniguchi πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 French βš– 449 KB πŸ‘ 1 views

## I The effects of vaso-active intestinal peptide (VIP) on gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) were investigated in Wistar rats given VIP every other day for 27 weeks after oral administration of MNNG for 25 weeks. In week 52, administration of VIP caused

Enhancement by tyrosine methyl ester of
✍ Masaharu Tatsuta; Hiroyasu Iishi; Miyako Baba; Haruo Taniguchi πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 French βš– 471 KB πŸ‘ 1 views

The effect of tyrosine methyl ester (TME) on the incidence, number, and histological types of gastric cancers induced by N-methyl-N'-nitro-N-nitroroguanidine (MNNG) was investigated in male Wistar rats. Rats were subcutaneously given TME, 5 I 2 mg/kg body weight, every other day after 20 weeks of or